Research shows the Affordable Care Act helps farmers get better health care and avoid emergency rooms.

Published Date: 17 Feb 2023

More than 2.5 million agricultural workers help maintain America's food supply. They play an important role in the economy, but their work is difficult and often dangerous.

Read Full News

Latest News

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

6 Ophthalmology Headlines You Missed in October 2025

6 Ophthalmology Headlines You Missed in October 2025

New Parameters for Faster Geographic Atrophy Progression Established, with Srinivas Sadda, MD Srinivas Sadda, MD

The pooled sham cohorts of the OAKS and DERBY trials have revealed a series of indicators for faster geographic atrophy lesion growth.

OCU-410 Gene Therapy Preserves Visual Acuity and Slows GA Lesion Progression, with Jay Chhablani, MD Jay Chhablani, MD

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Intravitreal UBX1325 Shows Efficacy in Diabetic Retinopathy, DME, with Dante Pieramici, MD Dante J. Pieramici, MD

Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.

Todays Updates

NeurologyLive® Year in Review 2025: Notable Trials Beginning This Year NeurologyLive® Staff

As part of NeurologyLive®'s Year in Review 2025, we've compiled some notable trials that began in 2025.

NeuroVoices: Joseph Sullivan, MD, on ETX101 Gene Regulation Therapy and Early POLARIS Findings in Dravet Syndrome Marco Meglio

The director of the Pediatric Epilepsy Center at UCSF reviewed recently presented interim phase 1/2 data for ETX101, a one-time AAV9 gene regulation therapy aiming to increase SCN1A expression in inhibitory interneurons in Dravet syndrome.

NeurologyLive® Year in Review 2025: Top Interviews in Multiple Sclerosis Care NeurologyLive® Staff

As part of NeurologyLive®'s Year in Review, take a look at our top expert interviews regarding multiple sclerosis in 2025.

Hidradenitis Suppurativa in 2025: Year in Review

Hidradenitis Suppurativa in 2025: Year in Review

Todays Updates

NeurologyLive® Year in Review 2025: Notable Trials Beginning This Year NeurologyLive® Staff

As part of NeurologyLive®'s Year in Review 2025, we've compiled some notable trials that began in 2025.

NeuroVoices: Joseph Sullivan, MD, on ETX101 Gene Regulation Therapy and Early POLARIS Findings in Dravet Syndrome Marco Meglio

The director of the Pediatric Epilepsy Center at UCSF reviewed recently presented interim phase 1/2 data for ETX101, a one-time AAV9 gene regulation therapy aiming to increase SCN1A expression in inhibitory interneurons in Dravet syndrome.

NeurologyLive® Year in Review 2025: Top Interviews in Multiple Sclerosis Care NeurologyLive® Staff

As part of NeurologyLive®'s Year in Review, take a look at our top expert interviews regarding multiple sclerosis in 2025.

Hidradenitis Suppurativa in 2025: Year in Review

Hidradenitis Suppurativa in 2025: Year in Review

Latest News

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

6 Ophthalmology Headlines You Missed in October 2025

The pooled sham cohorts of the OAKS and DERBY trials have revealed a series of indicators for faster geographic atrophy lesion growth.

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.

News All Time

Childhood blindness: Recommended realignment of prevention, medical treatment in development cooperation

International health policy and German development cooperation focus primarily on preventive measures. This is evident, for example, in diseases such as childhood blindness, which can be prevented through vaccinations or ...

Demystifying a visual illusion: Why we see color that's not there

A new discovery has unraveled why we sometimes see colors that aren't there. The phenomenon of "color afterimages" is when you see illusory—or false—colors after staring at real colors for a longer time. Through this, ...

Better vision test enables precise detection of eye disorders in toddlers

The development of a new tool for testing the eyesight of children under three could mean more children receive treatment for vision difficulties earlier, leading to positive effects on learning and development.

Eye scans reveal clues to aging and heart disease risk, study finds

The tiny blood vessels in your eyes might hold the key to predicting a person's risk of developing heart disease and how fast they're biologically aging, according to researchers at McMaster University and Population Health ...

LASIK armed with 3D eye model provides better vision correction

An advanced form of LASIK (Laser-Assisted In-Situ Keratomileusis) eye surgery that uses a virtual 3D model of a person's eye appears to offer patients better vision, a new study says.

Fancy dress contact lenses can cause infections, ulcers, even blindness—how to keep your eyes safe this Halloween

With Halloween just around the corner, thousands will be shopping for fancy dress contact lenses to go with their costume. The appeal is clear, as their endless colors and shapes allow you to radically change how you look—who ...

Cataract surgery becoming an in-office procedure, experts say

Imagine popping by your eye doctor's office for a quick cataract surgery.

Age-related macular degeneration: Robot delivers ultra-precision injections with rapid setup times

Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex preparation required for robotic surgery still takes far too long. But a new robotic assistant for ...

Risk of eye disease increases during menopause transition

Many symptoms, such as hot flashes and vaginal dryness, are commonly associated with the menopause transition. One of the lesser-known symptoms that worsens in midlife is dry eyes. A new study suggests that postmenopausal ...

Pickleball popularity surge serves up spike in serious eye injuries

Rutgers New Jersey Medical School-led researchers have identified a striking rise in pickleball-related eye injuries among players visiting emergency departments across the United States. Using two decades of national surveillance ...

Transformative eye research expands donor pool for corneal transplant patients

Many eye banks won't accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail.

Like radar, a brain wave sweeps a cortical region to read out information held in working memory

Imagine you are a security guard in one of those casino heist movies where your ability to recognize an emerging crime will depend on whether you notice a subtle change on one of the many security monitors arrayed on your ...

Patient wealth is associated with quality of glaucoma care

Patients with newly diagnosed glaucoma who have less wealth or reside in rural communities are less likely to receive standard glaucoma care compared to wealthier patients, according to a recent multi-institutional study ...

FDA authorizes Essilor Stellest eyeglass lenses for children with myopia

The U.S. Food and Drug Administration has authorized marketing of the Essilor Stellest eyeglass lenses to correct myopia, with or without astigmatism, and to slow the progression of the disease in children 6 to 12 years old.

Vision therapy reverses concussion-related double and blurred vision, study finds

Nearly half of adolescents and young adults with lingering symptoms of concussion suffer from eye coordination disorders that cause double and blurred vision, headaches and difficulties concentrating.

Polyunsaturated fatty acid therapy reverses age-related vision decline in mice

Changes in vision are often a common sign of aging. But what if we could reverse age-related visual decline? In a new study, UC Irvine researchers explore a possible therapy for addressing "aging" in the eye and for preventing ...

Recommended News For You

CAR-T cell therapy for cancer causes 'brain fog,' study shows

Novel Agent for Chronic GVHD Wins FDA Approval

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

Use of marijuana and alcohol simultaneously is associated with worse outcomes.

Novel radiotracer identifies biomarker for triple-negative breast cancer

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

Recommended Articles For You

Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency 

Unlocking the Mystery of Ovarian Cancer Staging 

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease 

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Preoperative Embolization Linked to Relapse-Free Survival in Meningioma

2.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

3.

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

4.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

5.

Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024

1.

Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data

2.

Hemoglobin C: Understanding its Role in Sickle Cell Disease

3.

Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients

4.

Uncovering the Mystery of Burkitt's Lymphoma: A New Hope for Treatment

5.

Unlocking the Power of Cryoprecipitate: A Comprehensive Guide

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

5.

Thromboprophylaxis In Medical Settings

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot